Tivantinib

Tivantinib is the first non-ATP-competitive c-Met inhibitor with Ki of 0.355 μM in a cell-free assay, little activity to Ron, and no inhibition to EGFR, InsR, PDGFRα or FGFR1/4. Tivantinib (ARQ 197) induces a G2/M arrest and apoptosis.
Supplier Selleck Chemicals
Product # S2753
Sku # S2753-10mM/1mL
Pricing 10mM/1mL, $117.00
Feedback